EYENOVIA INC. - COMMON STOCK

Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi™ for In-Office Pupil Dilation

13 дек 2022 08:00:02 Источник Nasdaq GlobeNewswire

Eyenovia Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice President

08 дек 2022 08:00:01 Источник Nasdaq GlobeNewswire

Eyenovia Announces $15 Million Credit Facility with Avenue Venture Debt Fund

29 ноя 2022 08:00:00 Источник Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming BTIG Ophthalmology Day

23 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire

Eyenovia Reports Third Quarter 2022 Financial Results and Provides Business Update

10 ноя 2022 16:05:04 Источник Nasdaq GlobeNewswire

Eyenovia to Report Third Quarter 2022 Results on Thursday, November 10

03 ноя 2022 08:00:02 Источник Nasdaq GlobeNewswire

Eyenovia to Present at the American Academy of Optometry’s Annual Meeting

21 окт 2022 08:00:00 Источник Nasdaq GlobeNewswire

Eyenovia Announces Positive Results from VISION-2 Phase 3 Study of MicroLine as a Potential On-Demand Treatment for Presbyopia

20 окт 2022 08:00:02 Источник Nasdaq GlobeNewswire

Eyenovia Announces Planned Retirement of Lead Independent Director Ken Lee, Jr.

30 сен 2022 08:00:00 Источник Nasdaq GlobeNewswire

Eyenovia to Present at Upcoming Healthcare Conferences

07 сен 2022 08:00:03 Источник Nasdaq GlobeNewswire

Eyenovia to Participate in Multiple Medical Meetings in September

06 сен 2022 08:00:03 Источник Nasdaq GlobeNewswire

Eyenovia Reports Second Quarter 2022 Financial Results

10 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire

Eyenovia to Report Second Quarter 2022 Results on Wednesday, August 10

04 авг 2022 08:00:02 Источник Nasdaq GlobeNewswire

Eyenovia Announces Appointment of Ophthalmic Industry Veteran Michael Rowe as Chief Executive Officer and Board Member

27 июл 2022 08:00:03 Источник Nasdaq GlobeNewswire

Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations

18 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire

Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors

07 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire

Eyenovia Strategic Partner Arctic Vision Enrolls First Patient in Phase III Clinical Trial of ARVN003 (MicroLine) for Presbyopia in China

06 июл 2022 08:00:02 Источник Nasdaq GlobeNewswire

UPDATE: Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

09 июн 2022 10:09:12 Источник Nasdaq GlobeNewswire

Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

09 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire

Eyenovia Announces Planned Chief Executive Officer Transition

07 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire